Single Injection of Local Anesthetic
Phase 1Completed 0 watching 0 views this week💤 Quiet
30
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Rotator Cuff Injury
Conditions
Rotator Cuff Injury
Trial Timeline
Jun 1, 2011 → Jan 1, 2013
NCT ID
NCT01355757About Single Injection of Local Anesthetic
Single Injection of Local Anesthetic is a phase 1 stage product being developed by Baxter for Rotator Cuff Injury. The current trial status is completed. This product is registered under clinical trial identifier NCT01355757. Target conditions include Rotator Cuff Injury.
Hype Score Breakdown
Clinical
10
Activity
5
Company
7
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01355757 | Phase 1 | Completed |
Competing Products
5 competing products in Rotator Cuff Injury
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Secukinumab + Placebo | Novartis | Phase 3 | 77 |
| Secukinumab + Placebo | Novartis | Phase 3 | 77 |
| BMP-655/ACS+Standard of care or Standard of care + BMP-655/ACS+Standard of care or Standard of care + BMP-655/ACS+Standard of care or Standard of care | Pfizer | Phase 1 | 32 |
| BMP-655/ACS or Standard of Care + BMP-655/ACS or Standard of Care + BMP-655/ACS or Standard of Care | Pfizer | Phase 1 | 32 |
| Pregabalin | Viatris | Approved | 82 |